Moreover, GLI inhibitor has a pro-apoptotic effect on myeloid leukemia cells and hepatocellular carcinoma cells by changing the morphogenesis of apoptosis and activating caspase-353,54. Here, GLI1 is linked to hepatocellular carcinoma.